Clinical Immunization Safety Assessment (CISA) Network Publications

CDC. Syncope after vaccination--United States, January 2005--July 2007. MMWR. 2008;57(17):457-460.

Batten BC, Sparks RC, Slade BA. The Clinical Immunization Safety Assessment (CISA: network: conducting clinical research in vaccine safety." National Immunization Conference. Atlanta, GA. March 17-20, 2008.

Haber P, Sejvar J, Slade B, Mikaeloff M, DeStefano F. Vaccines and Gillain Barre Syndrome: A literature review, in preparation.

Hua W, Izurieta HS, Slade B, Belay ED, Haber P, Tiernan R, Woo EJ, Iskander J, Braun MM, Ball R. Kawasaki disease after vaccination: Reports to the Vaccine Adverse Event Reporting System 1990-2000, in preparation.

Huang WT, Miller ER, Broder KR, Slade BA, Gee J, Kroger A, Markowitz L, Iskander J. "Syncope and related injuries after vaccination." National Immunization Conference. Atlanta, GA. March 17-20, 2008.

Klein NP, Fireman B, Enright A, Ray P, Black S, Dekker CL; Clinical Immunization Safety Assessment Network. A role for genetics in the immune response to the varicella vaccine. Pediatric Infectious Disease Journal 2007;26(4):300–305.

LaRussa P, Edwards K, Dekker C, Klein NP, Halsey N, Marchant C, Baxter R, Engler R, Kissner J, Slade B. The Clinical Immunzation Safety Assessment (CISA) initiative, a progress report: 2001-2008, in preparation.

Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta H, Slade B, Ball R, Miller N, Braun M, Markowitz L, Iskander J. Postlicensure safety surveillance for quadrivalent human human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, June 2006 to June 2007, in preparation.

Miller ER, Hibbs BF, Slade BA. "Vaccination administration errors reported to the vaccine adverse events reporting system (VAERS).National Immunization Conference. Atlanta, GA. March 17-20, 2008.

Muralles AA, Ray P, Black S, Shinefield H, Casey CG, Campbell S, Chen RT; Clinical Immunization Safety Assessment Network. Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients. Vaccine 2006;24(4):476–484.

Slade B. "Clinical Immunization Safety Assessment (CISA) network: activities related to human papillomavirus vaccine (HPV4)" Atlanta, GA. October 22, 2008.

Slade B. "Public health genomics trainee experience at CDC: genomics and immunization." The 5th CDC Public Health Genomics Collaboration Meeting. Atlanta, GA. May 12, 2008.

Slade, BA, Gargiullo P, Batten B, Iskander J, CISA, VSD. "Vaccine safety in the era of genomics." CDC's 10th year anniversary of public health genomics. Atlanta, GA. Jan. 23, 2008.

Sekaran NK, Edwards KM. Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccine. Pediatric Infectious Disease Journal 2006;25(4):374–375.

Tatti KM, Slade BA, Patel M, Messonier NR, Jackson T, Kirkland K, Talbot E, Tondella ML. Real-time polymerase chain reaction detection of Bordetella pertussis DNA in acellular pertussis vaccines. Pediactrics Infectious Disease Journal 2008;27(1):73-74.

Wood R, Setse R, Halsey NA; Clinical Immunization Safety Assessment Network Hypersensitivity Working Group. Irritant skin test reactions to common vaccines. Journal of Allergy and Clinical Immunology 2007;120(2):478–481.

Wood Robert A, Berger M, Dreskin SC, Setse R, Engler RJM, Dekker CL, Halsey NA, Working Group of the Clinical Immunization Safety Assessment (CISA) Network. An Algorithm for Treatment of Patients With Hypersensitivity Reactions After Vaccines. Pediatrics 2008;122(3):e771-e777.